Kanvas Biosciences
Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy
$48MSeries A
Role not disclosedKT
Ki Tua Fund
Activity from announced rounds
Activity in this selectionearlybird-venture-capital-327ce1a4
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $50M 2 disclosed · full round size, not this investor’s share